# CYP27A1

## Overview
CYP27A1 is a gene that encodes the enzyme cytochrome P450 family 27 subfamily A member 1, also known as sterol 27-hydroxylase. This enzyme is a member of the cytochrome P450 superfamily, which is involved in the metabolism of various substrates, including cholesterol and vitamin D3. As a mitochondrial enzyme, CYP27A1 plays a critical role in cholesterol homeostasis by catalyzing the conversion of cholesterol into bile acids, which are essential for lipid digestion and absorption. Additionally, it is involved in the bioactivation of vitamin D3, contributing to calcium homeostasis and skeletal health. Mutations in the CYP27A1 gene can lead to cerebrotendinous xanthomatosis (CTX), a rare lipid storage disorder characterized by the accumulation of cholestanol and cholesterol in tissues, resulting in neurological and systemic symptoms (Köroğlu2024Cerebrotendinous; Nie2014Cerebrotendinous). The enzyme's function and its interactions with other proteins are crucial for maintaining cholesterol balance and preventing metabolic disorders (Pikuleva1997Expression; Charvet2013Posttranslational).

## Structure
The CYP27A1 protein, a member of the cytochrome P450 superfamily, is involved in cholesterol metabolism and vitamin D3 activation. Its primary structure consists of a sequence of amino acids that form the basis for its functional conformation. The secondary structure includes alpha-helices and beta-sheets, which contribute to the protein's stability and function (Pikuleva2008Studies). The tertiary structure of CYP27A1 is characterized by a compact, globular shape with a heme-binding domain, essential for its enzymatic activity (Mast2006Distinct).

The protein interacts with membranes through specific regions, including the F-G loop and parts of the F and G helices, which are involved in membrane interaction (Pikuleva2008Studies). These regions are crucial for the protein's function in the mitochondrial environment. Although the complete quaternary structure is not detailed, the protein's interaction with substrates like cholesterol and 5β-cholestane-3α,7α,12α-triol suggests a dynamic active site that accommodates different orientations of these molecules (Mast2006Distinct).

Post-translational modifications such as phosphorylation and glycosylation may occur, although specific details are not provided in the context. The protein may also exist in different isoforms due to alternative splicing, contributing to its functional diversity. However, specific splice variant isoforms are not detailed in the available context.

## Function
The CYP27A1 gene encodes the enzyme sterol 27-hydroxylase, which plays a crucial role in cholesterol metabolism and homeostasis. This enzyme is involved in the conversion of cholesterol into more polar metabolites, such as 27-hydroxycholesterol and 3β-hydroxy-5-cholestenoic acid, facilitating their transport out of cells. These metabolites are then taken up by the liver and converted into bile acids, which are essential for lipid digestion and absorption (Lund1994Atherosclerosis; von2002Mechanism). 

Sterol 27-hydroxylase is a mitochondrial cytochrome P450 enzyme that catalyzes multiple oxidation reactions in the bile acid biosynthesis pathway. It hydroxylates cholesterol at carbon 27, initiating the degradation of the C27-steroid side chain, a key step in bile acid synthesis (Norlin2003On; Cali1991Characterization). The enzyme is expressed in various tissues, including the liver, macrophages, and tendons, indicating its role in both hepatic and extrahepatic cholesterol metabolism (QUINN2005Expression; von2002Mechanism).

In addition to its role in cholesterol metabolism, CYP27A1 is involved in the bioactivation of vitamin D3, converting it into its active form, which is crucial for calcium homeostasis and skeletal integrity (Tieu2012Metabolism; Sawada2000Metabolism). The enzyme's activity is essential for maintaining cholesterol balance and preventing conditions such as atherosclerosis and cerebrotendinous xanthomatosis (CTX) (Lund1994Atherosclerosis; Norlin2003On).

## Clinical Significance
Mutations in the CYP27A1 gene are primarily associated with cerebrotendinous xanthomatosis (CTX), a rare autosomal recessive lipid storage disorder. CTX is characterized by the accumulation of cholestanol and cholesterol in various tissues, leading to a range of symptoms including neurological dysfunction, juvenile cataracts, tendon xanthomas, and premature atherosclerosis (Brlek2023Successful; Schneider2010A; Nie2014Cerebrotendinous). The disease results from impaired bile acid synthesis due to the loss of function of the sterol 27-hydroxylase enzyme encoded by CYP27A1 (Köroğlu2024Cerebrotendinous).

Clinical manifestations of CTX can vary significantly among patients, with some experiencing early-onset symptoms such as chronic diarrhea and cataracts, while others may develop progressive neurological issues like ataxia, dementia, and peripheral neuropathy (Lipiński2021Sterol; Brlek2023Successful). Genetic testing for mutations in CYP27A1 is crucial for diagnosing CTX, and early treatment with chenodeoxycholic acid (CDCA) can improve clinical outcomes by reducing the accumulation of toxic bile acid intermediates (Yoshinaga2014Clinical; Brlek2023Successful).

Alterations in CYP27A1 expression have also been linked to other conditions, such as coronary artery disease, due to its role in cholesterol homeostasis and reverse cholesterol transport (InanlooRahatloo2013Mutation). The gene's involvement in cholesterol metabolism suggests potential implications for various metabolic and cardiovascular diseases.

## Interactions
CYP27A1, also known as cytochrome P450c27, is a mitochondrial enzyme that interacts with several proteins essential for its function. It requires the electron transfer proteins adrenodoxin (Adx) and adrenodoxin reductase (Adr) to facilitate its enzymatic activity. These interactions are crucial for the hydroxylation of cholesterol and other sterol intermediates in the mitochondria (Pikuleva1997Expression).

CYP27A1 exhibits a significantly higher binding affinity for Adx compared to another mitochondrial P450 enzyme, P450scc (CYP11A1). This tighter binding is attributed to specific electrostatic interactions involving positively charged residues, such as Lys-354, Lys-358, and Arg-418, which are essential for the interaction with Adx. Mutations in these residues can significantly alter the binding properties, indicating their critical role in maintaining the interaction (Pikuleva1999An).

The interaction between CYP27A1 and Adx is also influenced by posttranslational modifications. For instance, the adduction of isolevuglandin to Lys-358 impairs the interaction with Adx, thereby diminishing the enzyme's activity (Charvet2013Posttranslational). These interactions highlight the importance of specific amino acid residues and modifications in regulating CYP27A1's function.


## References


[1. (Tieu2012Metabolism) Elaine W. Tieu, Wei Li, Jianjun Chen, Donna M. Baldisseri, Andrzej T. Slominski, and Robert C. Tuckey. Metabolism of cholesterol, vitamin d3 and 20-hydroxyvitamin d3 incorporated into phospholipid vesicles by human cyp27a1. The Journal of Steroid Biochemistry and Molecular Biology, 129(3–5):163–171, April 2012. URL: http://dx.doi.org/10.1016/j.jsbmb.2011.11.012, doi:10.1016/j.jsbmb.2011.11.012. This article has 42 citations.](https://doi.org/10.1016/j.jsbmb.2011.11.012)

[2. (Schneider2010A) Hauke Schneider, Alexandra Lingesleben, Hans-Peter Vogel, Rita Garuti, and Sebastiano Calandra. A novel mutation in the sterol 27-hydroxylase gene of a woman with autosomal recessive cerebrotendinous xanthomatosis. Orphanet Journal of Rare Diseases, October 2010. URL: http://dx.doi.org/10.1186/1750-1172-5-27, doi:10.1186/1750-1172-5-27. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1750-1172-5-27)

[3. (QUINN2005Expression) Carmel M. QUINN, Wendy JESSUP, Jenny WONG, Leonard KRITHARIDES, and Andrew J. BROWN. Expression and regulation of sterol 27-hydroxylase (cyp27a1) in human macrophages: a role for rxr and pparγ ligands. Biochemical Journal, 385(3):823–830, January 2005. URL: http://dx.doi.org/10.1042/bj20041776, doi:10.1042/bj20041776. This article has 58 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20041776)

[4. (Pikuleva2008Studies) Irina A. Pikuleva, Natalia Mast, Wei‐Li Liao, and Illarion V. Turko. Studies of membrane topology of mitochondrial cholesterol hydroxylases cyps 27a1 and 11a1. Lipids, 43(12):1127–1132, September 2008. URL: http://dx.doi.org/10.1007/s11745-008-3234-x, doi:10.1007/s11745-008-3234-x. This article has 16 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s11745-008-3234-x)

[5. (Charvet2013Posttranslational) Casey D. Charvet, James Laird, Yunfeng Xu, Robert G. Salomon, and Irina A. Pikuleva. Posttranslational modification by an isolevuglandin diminishes activity of the mitochondrial cytochrome p450 27a1. Journal of Lipid Research, 54(5):1421–1429, May 2013. URL: http://dx.doi.org/10.1194/jlr.m035790, doi:10.1194/jlr.m035790. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1194/jlr.m035790)

[6. (Brlek2023Successful) Petar Brlek, Luka Bulić, David Glavaš Weinberger, Jelena Bošnjak, Tomislav Pavlović, Svetlana Tomić, Zdravka Krivdić Dupan, Igor Borić, and Dragan Primorac. Successful treatment of a rare cholesterol homeostasis disorder due to cyp27a1 gene mutation with chenodeoxycholic acid therapy. Biomedicines, 11(5):1430, May 2023. URL: http://dx.doi.org/10.3390/biomedicines11051430, doi:10.3390/biomedicines11051430. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biomedicines11051430)

[7. (Lipiński2021Sterol) Patryk Lipiński, Maja Klaudel-Dreszler, Elzbieta Ciara, Dorota Jurkiewicz, Rafał Płoski, Joanna Cielecka-Kuszyk, Piotr Socha, and Irena Jankowska. Sterol 27-hydroxylase deficiency as a cause of neonatal cholestasis: report of 2 cases and review of the literature. Frontiers in Pediatrics, January 2021. URL: http://dx.doi.org/10.3389/fped.2020.616582, doi:10.3389/fped.2020.616582. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fped.2020.616582)

[8. (Pikuleva1999An) Irina A. Pikuleva, Carolyn Cao, and Michael R. Waterman. An additional electrostatic interaction between adrenodoxin and p450c27 (cyp27a1) results in tighter binding than between adrenodoxin and p450scc (cyp11a1). Journal of Biological Chemistry, 274(4):2045–2052, January 1999. URL: http://dx.doi.org/10.1074/JBC.274.4.2045, doi:10.1074/jbc.274.4.2045. This article has 67 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.274.4.2045)

[9. (InanlooRahatloo2013Mutation) Kolsoum InanlooRahatloo, Amir Farhang Zand Parsa, Klaus Huse, Paniz Rasooli, Saeid Davaran, Matthias Platzer, Jian-Bing Fan, Sasan Amini, Frank Steemers, and Elahe Elahi. Mutation in cyp27a1 identified in family with coronary artery disease. European Journal of Medical Genetics, 56(12):655–660, December 2013. URL: http://dx.doi.org/10.1016/j.ejmg.2013.09.008, doi:10.1016/j.ejmg.2013.09.008. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejmg.2013.09.008)

[10. (Mast2006Distinct) Natalia Mast, Dilyara Murtazina, Hong Liu, Sandra E. Graham, Ingemar Bjorkhem, James R. Halpert, Julian Peterson, and Irina A. Pikuleva. Distinct binding of cholesterol and 5β-cholestane-3α,7α,12α-triol to cytochrome p450 27a1: evidence from modeling and site-directed mutagenesis studies. Biochemistry, 45(14):4396–4404, March 2006. URL: http://dx.doi.org/10.1021/bi052654w, doi:10.1021/bi052654w. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi052654w)

[11. (von2002Mechanism) Sara von Bahr, Tomas Movin, Nikos Papadogiannakis, Irina Pikuleva, Per Rönnow, Ulf Diczfalusy, and Ingemar Björkhem. Mechanism of accumulation of cholesterol and cholestanol in tendons and the role of sterol 27-hydroxylase (cyp27a1). Arteriosclerosis, Thrombosis, and Vascular Biology, 22(7):1129–1135, July 2002. URL: http://dx.doi.org/10.1161/01.atv.0000022600.61391.a5, doi:10.1161/01.atv.0000022600.61391.a5. This article has 65 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1161/01.atv.0000022600.61391.a5)

[12. (Norlin2003On) Maria Norlin, Sara von Bahr, Ingemar Björkhem, and Kjell Wikvall. On the substrate specificity of human cyp27a1. Journal of Lipid Research, 44(8):1515–1522, August 2003. URL: http://dx.doi.org/10.1194/JLR.M300047-JLR200, doi:10.1194/jlr.m300047-jlr200. This article has 70 citations and is from a peer-reviewed journal.](https://doi.org/10.1194/JLR.M300047-JLR200)

[13. (Cali1991Characterization) J J Cali and D W Russell. Characterization of human sterol 27-hydroxylase. a mitochondrial cytochrome p-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. Journal of Biological Chemistry, 266(12):7774–7778, April 1991. URL: http://dx.doi.org/10.1016/s0021-9258(20)89517-9, doi:10.1016/s0021-9258(20)89517-9. This article has 285 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(20)89517-9)

[14. (Pikuleva1997Expression) Irina A. Pikuleva, Ingemar Björkhem, and Michael R. Waterman. Expression, purification, and enzymatic properties of recombinant human cytochrome p450c27 (cyp27). Archives of Biochemistry and Biophysics, 343(1):123–130, July 1997. URL: http://dx.doi.org/10.1006/abbi.1997.0142, doi:10.1006/abbi.1997.0142. This article has 78 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/abbi.1997.0142)

[15. (Sawada2000Metabolism) Natsumi Sawada, Toshiyuki Sakaki, Miho Ohta, and Kuniyo Inouye. Metabolism of vitamin d3 by human cyp27a1. Biochemical and Biophysical Research Communications, 273(3):977–984, July 2000. URL: http://dx.doi.org/10.1006/BBRC.2000.3050, doi:10.1006/bbrc.2000.3050. This article has 134 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/BBRC.2000.3050)

[16. (Köroğlu2024Cerebrotendinous) Muhammed Köroğlu, Mustafa Karakaplan, Enes Gündüz, Betül Kesriklioğlu, Emre Ergen, Okan Aslantürk, and Zeynep Maraş Özdemir. Cerebrotendinous xanthomatosis patients with late diagnosed in single orthopedic clinic: two novel variants in the cyp27a1 gene. Orphanet Journal of Rare Diseases, February 2024. URL: http://dx.doi.org/10.1186/s13023-024-03082-4, doi:10.1186/s13023-024-03082-4. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13023-024-03082-4)

[17. (Yoshinaga2014Clinical) Tsuneaki Yoshinaga, Yoshiki Sekijima, Shingo Koyama, Keiko Maruyama, Toshikazu Yoshida, Takeo Kato, and Shu-ichi Ikeda. Clinical and radiological findings of a cerebrotendinous xanthomatosis patient with a novel p.a335v mutation in the &lt;i&gt;cyp27a1&lt;/i&gt; gene. Internal Medicine, 53(23):2725–2729, 2014. URL: http://dx.doi.org/10.2169/INTERNALMEDICINE.53.2996, doi:10.2169/internalmedicine.53.2996. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.2169/INTERNALMEDICINE.53.2996)

[18. (Nie2014Cerebrotendinous) Shuke Nie, Guiqin Chen, Xuebing Cao, and Yunjian Zhang. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet Journal of Rare Diseases, November 2014. URL: http://dx.doi.org/10.1186/s13023-014-0179-4, doi:10.1186/s13023-014-0179-4. This article has 235 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13023-014-0179-4)

[19. (Lund1994Atherosclerosis) E. Lund, O. Andersson, U. Diczfalusy, and I. Bjo¨rkhem. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Atherosclerosis, 109(1–2):123, September 1994. URL: http://dx.doi.org/10.1016/0021-9150(94)93503-3, doi:10.1016/0021-9150(94)93503-3. This article has 0 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/0021-9150(94)93503-3)